2 recruiting, 1 unknown. 1 Not applicable, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Unknown 1 |
| Phase 2 | 1 | Recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Methotrexate Injection: new trials by email Literature Review of Methotrexate Injection trials Research Report on Methotrexate Injection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prevention of ProliFerative Vitreoretinopathy With Intravitreal MethotreXate in Primary Retinal DEtachment Repair (FIXER) Trial Methotrexate Injection, Methotrexate Infusion, Sham Injection - Proliferative Vitreoretinopathy, Rhegmatogenous Retinal Detachment | Phase 2 | Recruiting | Cincinnati Eye Institute, Southwest Ohio | 860 | 2024-03-01 | 2026-10-29 |
| Methotrexate Alone vs Combination With Excimer Light in Nail Psoriasis Excimer laser, Methotrexate Injection - Nail Psoriasis | Not applicable | Unknown | Assiut University | 20 | 2023-12-01 | 2023-12-01 |
| A Study to Evaluate MRG003 vs Cetuximab/Methotrexate in in the Treatment of Patients With RM-SCCHN MRG003, Cetuximab injection, Methotrexate Injection - Squamous Cell Carcinoma of the Head and Neck | Phase 3 | Recruiting | Lepu Biopharma Co., Ltd. | 180 | 2023-04-04 | 2026-09-04 |
Squamous Cell Carcinoma of Head and Neck (1) · Vitreoretinopathy, Proliferative (1)
Assiut University (1) · Cincinnati Eye Institute, Southwest Ohio (1) · Lepu Biopharma Co., Ltd. (1)
China (1) · Egypt (1) · United States (1)
Sahar Abdel-Moez, MD (1) · Ye Guo, PhD (1)